Last update 24 Mar 2025

DSP-3077

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DSP 3077, DSP3077
Target-
Action-
Mechanism-
Therapeutic Areas
Congenital DisordersEye DiseasesOther Diseases
Active Indication
Retinitis Pigmentosa
Inactive Indication-
Originator Organization
Enzyvant Therapeutics GmbHEnzyvant Therapeutics GmbHStartup
Active Organization
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.Enzyvant Therapeutics GmbHEnzyvant Therapeutics GmbHStartupSumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DSP-3077
NCT06891885
/ Not yet recruitingPhase 1/2
A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-derived Retinal Sheets (DSP-3077) in Adults with Retinitis Pigmentosa (RP)
100 Clinical Results associated with DSP-3077
Login to view more data
100 Translational Medicine associated with DSP-3077
Login to view more data
100 Patents (Medical) associated with DSP-3077
Login to view more data
100 Deals associated with DSP-3077
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinitis PigmentosaPhase 2-
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.
01 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free